CLSPN基因多态和酒精消费之间的相互作用有助于口腔癌的进展
Ming-Ju Hsieh1,2,3, Yu-Sheng Lo1, Hsin-Yu Ho1
1Oral Cancer Research Center, Changhua Christian Hospital, Changhua 500, Taiwan.
International journal of molecular sciences
|January 23, 2024
概括
克拉斯 (CLSPN) 基因单核酸多态 (SNPs) 与口腔癌的发展有关. rs7520495 SNP与口腔状细胞癌 (OSCC) 患者的细胞分化不良有关,特别是吸烟者.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 单核酸多态 (SNP) 显著影响疾病风险和进展.
- 克拉斯 (CLSPN) 基因变异与癌症有关,但它们在口腔癌中的特定作用需要进一步调查.
- 关于CLSPN基因型与口腔癌之间的联系的文献有限.
研究的目的:
- 调查CLSPN基因多态化与口腔状细胞癌 (OSCC) 的发展之间的相关性.
- 分析特定的CLSPNSNP (rs12058760,rs16822339,rs535638,rs7520495) 与OSCC风险和临床病理特征的关联.
- 探索CLSPN基因变异在口腔癌进展和患者结局中的潜在作用.
主要方法:
- 在402个OSCC病例和304个无癌症对照中对四个CLSPNSNP进行基因型分析.
- 对基因型频率及其与OSCC风险的关联进行统计分析,考虑个体习惯.
- 使用癌症基因组图谱 (TCGA) 数据集探索CLSPN表达及其与细胞分化的相关性.
主要成果:
- 当单独分析研究的CLSPNSNP时,没有观察到OSCC风险的显著差异.
- rs7520495 SNP,特别是CC + GG基因型,与OSCC患者的细胞差异化增加显著相关 (AOR: 1.998).
- 患有rs7520495的G基因型患者表现出较高的细胞差异化发病率 (AOR:4.736),特别是在饮酒者中.
- 根据TCGA数据,更高的CLSPN表达水平与口腔癌中较差的细胞分化相关.
结论:
- CLSPN 基因多态化有助于口腔癌的发展.
- rs7520495 SNP是口腔癌中细胞分化不良的潜在预测因素.
- 需要进一步的研究来确定rs7520495作为预测口腔癌患者复发,治疗反应和药物毒性的生物标志物.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


